Orchard Therapeutics plc Annual Costs and Expenses in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Orchard Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Costs and Expenses for the quarter ending September 30, 2023 was $27.9M, a 10.7% decline year-over-year.
  • Orchard Therapeutics plc Costs and Expenses for the twelve months ending September 30, 2023 was $124M, a 16.3% decline year-over-year.
  • Orchard Therapeutics plc annual Costs and Expenses for 2022 was $150M, a 5.37% increase from 2021.
  • Orchard Therapeutics plc annual Costs and Expenses for 2021 was $142M, a 10.9% decline from 2020.
  • Orchard Therapeutics plc annual Costs and Expenses for 2020 was $160M, a 9.02% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $150M +$7.64M +5.37% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $142M -$17.5M -10.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $160M -$15.8M -9.02% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $175M -$61.7M -26% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $237M +$199M +516% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $38.5M +$19.3M +101% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $19.2M Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.